Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant
- PMID: 2392685
- DOI: 10.1126/science.2392685
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant
Erratum in
-
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: corrections and clarifications.Science. 1991 Feb 15;251(4995):811. doi: 10.1126/science.1990444. Science. 1991. PMID: 1990444 No abstract available.
Abstract
The principal neutralizing determinant (PND) of human immunodeficiency virus HIV-1 is part of a disulfide bridged loop in the third variable region of the external envelope protein, gp120. Analysis of the amino acid sequences of this domain from 245 different HIV-1 isolates revealed that the PND is less variable than thought originally. Conservation to better than 80 percent of the amino acids in 9 out of 14 positions in the central portion of the PND and the occurrence of particular oligopeptide sequences in a majority of the isolates suggest that there are constraints on PND variability. One constraining influence may be the structural motif (beta strand--type II beta turn--beta strand--alpha helix) predicted for the consensus PND sequence by a neural network approach. Isolates with a PND similar to the commonly investigated human T cell lymphoma virus IIIB (HTLV-IIIB) and LAV-1 (BRU) strains were rare, and only 14 percent of sera from 86 randomly selected HIV-1 seropositive donors contained antibodies that recognized the PND of these virus isolates. In contrast, over 65 percent of these sera reacted with peptides containing more common PND sequences. These results suggest that HIV vaccine immunogens chosen because of their similarity to the consensus PND sequence and structure are likely to induce antibodies that neutralize a majority of HIV-1 isolates.
Similar articles
-
High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.AIDS Res Hum Retroviruses. 1991 Oct;7(10):831-8. doi: 10.1089/aid.1991.7.831. AIDS Res Hum Retroviruses. 1991. PMID: 1720630
-
Antibodies of HIV-1 positive subjects and experimentally immunized primates and rodents bind to sequence divergent regions of the third variable domain (V3) of gp120.Int Immunol. 1992 Feb;4(2):283-94. doi: 10.1093/intimm/4.2.283. Int Immunol. 1992. PMID: 1377948
-
Induction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein.Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):631-5. doi: 10.1073/pnas.92.2.631. Proc Natl Acad Sci U S A. 1995. PMID: 7831341 Free PMC article.
-
[Peptides from the principal neutralizing and CD4-binding domain: similar immunoreactive properties and structure pattern].Vestn Ross Akad Med Nauk. 1992;(9-10):47-52. Vestn Ross Akad Med Nauk. 1992. PMID: 1283721 Review. Russian.
-
High antigenic cross-reactivity of the V3 consensus sequences of HIV-1 gp120.AIDS Res Hum Retroviruses. 1993 Dec;9(12):1209-15. doi: 10.1089/aid.1993.9.1209. AIDS Res Hum Retroviruses. 1993. PMID: 7511395
Cited by
-
The chemokine receptor CCR5: multi-faceted hook for HIV-1.Retrovirology. 2024 Jan 23;21(1):2. doi: 10.1186/s12977-024-00634-1. Retrovirology. 2024. PMID: 38263120 Free PMC article. Review.
-
Novel small synthetic HIV-1 V3 crown variants: CCR5 targeting ligands.J Biochem. 2022 Sep 5;172(3):149-164. doi: 10.1093/jb/mvac052. J Biochem. 2022. PMID: 35708645 Free PMC article.
-
Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application.Front Immunol. 2021 Jul 20;12:697683. doi: 10.3389/fimmu.2021.697683. eCollection 2021. Front Immunol. 2021. PMID: 34354709 Free PMC article.
-
V3-Loop genotypes do not predict maraviroc susceptibility of CCR5-tropic virus or clinical response through week 48 in HIV-1-infected, treatment-experienced persons receiving optimized background regimens.Antivir Chem Chemother. 2021 Jan-Dec;29:20402066211030380. doi: 10.1177/20402066211030380. Antivir Chem Chemother. 2021. PMID: 34343443 Free PMC article.
-
Identification and CRISPR/Cas9 Inactivation of the C1s Protease Responsible for Proteolysis of Recombinant Proteins Produced in CHO Cells.Biotechnol Bioeng. 2019 Sep;116(9):2130-2145. doi: 10.1002/bit.27016. Epub 2019 Jun 10. Biotechnol Bioeng. 2019. PMID: 31087560 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases